Israel Theranostics Market (2025-2031) | Forecast, Segmentation, Growth, Outlook, Size & Revenue, Competitive Landscape, Companies, Share, Industry, Trends, Value, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Theranostics Market Revenues & Volume, 2021 & 2031F

3.3 Israel Theranostics Market - Industry Life Cycle

3.4 Israel Theranostics Market - Porter's Five Forces

3.5 Israel Theranostics Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 Israel Theranostics Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in Israel leading to higher demand for personalized medicine solutions.

4.2.2 Technological advancements in diagnostic imaging and molecular diagnostics driving innovation in theranostics.

4.2.3 Growing investments in healthcare infrastructure and research facilities supporting the development and adoption of theranostics.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of theranostic products leading to delays in market entry.

4.3.2 Limited reimbursement policies for theranostic procedures affecting accessibility and affordability.

4.3.3 High costs associated with theranostic technologies impacting adoption rates among healthcare providers and patients.

6.1 Israel Theranostics Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 Israel Theranostics Market Revenues & Volume, By Product Type, 2021- 2031F

6.1.3 Israel Theranostics Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F

6.1.4 Israel Theranostics Market Revenues & Volume, By Immunohistochemistry (IHC), 2021- 2031F

6.1.5 Israel Theranostics Market Revenues & Volume, By In Situ Hybridization (ISH), 2021- 2031F

6.1.6 Israel Theranostics Market Revenues & Volume, By Sequencing, 2021- 2031F

6.1.7 Israel Theranostics Market Revenues & Volume, By Others, 2021- 2031F

6.2 Israel Theranostics Market, By Application

6.2.1 Overview and Analysis

6.2.2 Israel Theranostics Market Revenues & Volume, By Oncology, 2021- 2031F

6.2.3 Israel Theranostics Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F

6.2.4 Israel Theranostics Market Revenues & Volume, By Neurological Disorders, 2021- 2031F

6.2.5 Israel Theranostics Market Revenues & Volume, By Immunological Disorders, 2021- 2031F

6.2.6 Israel Theranostics Market Revenues & Volume, By Others, 2021- 2031F

7.1 Israel Theranostics Market Export to Major Countries

7.2 Israel Theranostics Market Imports from Major Countries

8.1 Adoption rate of theranostic technologies by healthcare facilities in Israel.

8.2 Number of research collaborations between academic institutions and industry players in the field of theranostics.

8.3 Rate of development and commercialization of new theranostic products in the Israeli market.

8.4 Patient satisfaction levels with theranostic services and outcomes.

8.5 Investments in infrastructure for personalized medicine and precision diagnostics in Israel.

9.1 Israel Theranostics Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 Israel Theranostics Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 Israel Theranostics Market Revenue Share, By Companies, 2024

10.2 Israel Theranostics Market Competitive Benchmarking, By Operating and Technical Parameters